Drug-Eluting Balloons-North America Market Status and Trend Report 2013-2023
Report Summary
Drug-Eluting Balloons-North America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Drug-Eluting Balloons industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole North America and Regional Market Size of Drug-Eluting Balloons 2013-2017, and development forecast 2018-2023
Main market players of Drug-Eluting Balloons in North America, with company and product introduction, position in the Drug-Eluting Balloons market
Market status and development trend of Drug-Eluting Balloons by types and applications
Cost and profit status of Drug-Eluting Balloons, and marketing status
Market growth drivers and challenges
The report segments the North America Drug-Eluting Balloons market as:
North America Drug-Eluting Balloons Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
United States
Canada
Mexico
North America Drug-Eluting Balloons Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Semi-Compliant Balloons
Non-Compliant Balloons
North America Drug-Eluting Balloons Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Treatment of In-stent Restenosis (ISR)
Treatment of Small Vessel Disease (SVD)
Treatment of Bifurcation Stenoses
Treatment of Primary Coronary Artery Disease
North America Drug-Eluting Balloons Market: Players Segment Analysis (Company and Product introduction, Drug-Eluting Balloons Sales Volume, Revenue, Price and Gross Margin):
Boston Scientific
Medtronic
Cook Medical
C.R. Bard
B. Braun
Eurocor GmbH
Blue Medical
Bayer
Aachen Resonance
Acrostak
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Drug-Eluting Balloons-North America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Drug-Eluting Balloons industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole North America and Regional Market Size of Drug-Eluting Balloons 2013-2017, and development forecast 2018-2023
Main market players of Drug-Eluting Balloons in North America, with company and product introduction, position in the Drug-Eluting Balloons market
Market status and development trend of Drug-Eluting Balloons by types and applications
Cost and profit status of Drug-Eluting Balloons, and marketing status
Market growth drivers and challenges
The report segments the North America Drug-Eluting Balloons market as:
North America Drug-Eluting Balloons Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
United States
Canada
Mexico
North America Drug-Eluting Balloons Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Semi-Compliant Balloons
Non-Compliant Balloons
North America Drug-Eluting Balloons Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Treatment of In-stent Restenosis (ISR)
Treatment of Small Vessel Disease (SVD)
Treatment of Bifurcation Stenoses
Treatment of Primary Coronary Artery Disease
North America Drug-Eluting Balloons Market: Players Segment Analysis (Company and Product introduction, Drug-Eluting Balloons Sales Volume, Revenue, Price and Gross Margin):
Boston Scientific
Medtronic
Cook Medical
C.R. Bard
B. Braun
Eurocor GmbH
Blue Medical
Bayer
Aachen Resonance
Acrostak
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF DRUG-ELUTING BALLOONS
1.1 Definition of Drug-Eluting Balloons in This Report
1.2 Commercial Types of Drug-Eluting Balloons
1.2.1 Semi-Compliant Balloons
1.2.2 Non-Compliant Balloons
1.3 Downstream Application of Drug-Eluting Balloons
1.3.1 Treatment of In-stent Restenosis (ISR)
1.3.2 Treatment of Small Vessel Disease (SVD)
1.3.3 Treatment of Bifurcation Stenoses
1.3.4 Treatment of Primary Coronary Artery Disease
1.4 Development History of Drug-Eluting Balloons
1.5 Market Status and Trend of Drug-Eluting Balloons 2013-2023
1.5.1 North America Drug-Eluting Balloons Market Status and Trend 2013-2023
1.5.2 Regional Drug-Eluting Balloons Market Status and Trend 2013-2023
CHAPTER 2 NORTH AMERICA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Drug-Eluting Balloons in North America 2013-2017
2.2 Consumption Market of Drug-Eluting Balloons in North America by Regions
2.2.1 Consumption Volume of Drug-Eluting Balloons in North America by Regions
2.2.2 Revenue of Drug-Eluting Balloons in North America by Regions
2.3 Market Analysis of Drug-Eluting Balloons in North America by Regions
2.3.1 Market Analysis of Drug-Eluting Balloons in United States 2013-2017
2.3.2 Market Analysis of Drug-Eluting Balloons in Canada 2013-2017
2.3.3 Market Analysis of Drug-Eluting Balloons in Mexico 2013-2017
2.4 Market Development Forecast of Drug-Eluting Balloons in North America 2018-2023
2.4.1 Market Development Forecast of Drug-Eluting Balloons in North America 2018-2023
2.4.2 Market Development Forecast of Drug-Eluting Balloons by Regions 2018-2023
CHAPTER 3 NORTH AMERICA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole North America Market Status by Types
3.1.1 Consumption Volume of Drug-Eluting Balloons in North America by Types
3.1.2 Revenue of Drug-Eluting Balloons in North America by Types
3.2 North America Market Status by Types in Major Countries
3.2.1 Market Status by Types in United States
3.2.2 Market Status by Types in Canada
3.2.3 Market Status by Types in Mexico
3.3 Market Forecast of Drug-Eluting Balloons in North America by Types
CHAPTER 4 NORTH AMERICA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Drug-Eluting Balloons in North America by Downstream Industry
4.2 Demand Volume of Drug-Eluting Balloons by Downstream Industry in Major Countries
4.2.1 Demand Volume of Drug-Eluting Balloons by Downstream Industry in United States
4.2.2 Demand Volume of Drug-Eluting Balloons by Downstream Industry in Canada
4.2.3 Demand Volume of Drug-Eluting Balloons by Downstream Industry in Mexico
4.3 Market Forecast of Drug-Eluting Balloons in North America by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF DRUG-ELUTING BALLOONS
5.1 North America Economy Situation and Trend Overview
5.2 Drug-Eluting Balloons Downstream Industry Situation and Trend Overview
CHAPTER 6 DRUG-ELUTING BALLOONS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN NORTH AMERICA
6.1 Sales Volume of Drug-Eluting Balloons in North America by Major Players
6.2 Revenue of Drug-Eluting Balloons in North America by Major Players
6.3 Basic Information of Drug-Eluting Balloons by Major Players
6.3.1 Headquarters Location and Established Time of Drug-Eluting Balloons Major Players
6.3.2 Employees and Revenue Level of Drug-Eluting Balloons Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 DRUG-ELUTING BALLOONS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Boston Scientific
7.1.1 Company profile
7.1.2 Representative Drug-Eluting Balloons Product
7.1.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of Boston Scientific
7.2 Medtronic
7.2.1 Company profile
7.2.2 Representative Drug-Eluting Balloons Product
7.2.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of Medtronic
7.3 Cook Medical
7.3.1 Company profile
7.3.2 Representative Drug-Eluting Balloons Product
7.3.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of Cook Medical
7.4 C.R. Bard
7.4.1 Company profile
7.4.2 Representative Drug-Eluting Balloons Product
7.4.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of C.R. Bard
7.5 B. Braun
7.5.1 Company profile
7.5.2 Representative Drug-Eluting Balloons Product
7.5.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of B. Braun
7.6 Eurocor GmbH
7.6.1 Company profile
7.6.2 Representative Drug-Eluting Balloons Product
7.6.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of Eurocor GmbH
7.7 Blue Medical
7.7.1 Company profile
7.7.2 Representative Drug-Eluting Balloons Product
7.7.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of Blue Medical
7.8 Bayer
7.8.1 Company profile
7.8.2 Representative Drug-Eluting Balloons Product
7.8.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of Bayer
7.9 Aachen Resonance
7.9.1 Company profile
7.9.2 Representative Drug-Eluting Balloons Product
7.9.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of Aachen Resonance
7.10 Acrostak
7.10.1 Company profile
7.10.2 Representative Drug-Eluting Balloons Product
7.10.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of Acrostak
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF DRUG-ELUTING BALLOONS
8.1 Industry Chain of Drug-Eluting Balloons
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF DRUG-ELUTING BALLOONS
9.1 Cost Structure Analysis of Drug-Eluting Balloons
9.2 Raw Materials Cost Analysis of Drug-Eluting Balloons
9.3 Labor Cost Analysis of Drug-Eluting Balloons
9.4 Manufacturing Expenses Analysis of Drug-Eluting Balloons
CHAPTER 10 MARKETING STATUS ANALYSIS OF DRUG-ELUTING BALLOONS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Drug-Eluting Balloons in This Report
1.2 Commercial Types of Drug-Eluting Balloons
1.2.1 Semi-Compliant Balloons
1.2.2 Non-Compliant Balloons
1.3 Downstream Application of Drug-Eluting Balloons
1.3.1 Treatment of In-stent Restenosis (ISR)
1.3.2 Treatment of Small Vessel Disease (SVD)
1.3.3 Treatment of Bifurcation Stenoses
1.3.4 Treatment of Primary Coronary Artery Disease
1.4 Development History of Drug-Eluting Balloons
1.5 Market Status and Trend of Drug-Eluting Balloons 2013-2023
1.5.1 North America Drug-Eluting Balloons Market Status and Trend 2013-2023
1.5.2 Regional Drug-Eluting Balloons Market Status and Trend 2013-2023
CHAPTER 2 NORTH AMERICA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Drug-Eluting Balloons in North America 2013-2017
2.2 Consumption Market of Drug-Eluting Balloons in North America by Regions
2.2.1 Consumption Volume of Drug-Eluting Balloons in North America by Regions
2.2.2 Revenue of Drug-Eluting Balloons in North America by Regions
2.3 Market Analysis of Drug-Eluting Balloons in North America by Regions
2.3.1 Market Analysis of Drug-Eluting Balloons in United States 2013-2017
2.3.2 Market Analysis of Drug-Eluting Balloons in Canada 2013-2017
2.3.3 Market Analysis of Drug-Eluting Balloons in Mexico 2013-2017
2.4 Market Development Forecast of Drug-Eluting Balloons in North America 2018-2023
2.4.1 Market Development Forecast of Drug-Eluting Balloons in North America 2018-2023
2.4.2 Market Development Forecast of Drug-Eluting Balloons by Regions 2018-2023
CHAPTER 3 NORTH AMERICA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole North America Market Status by Types
3.1.1 Consumption Volume of Drug-Eluting Balloons in North America by Types
3.1.2 Revenue of Drug-Eluting Balloons in North America by Types
3.2 North America Market Status by Types in Major Countries
3.2.1 Market Status by Types in United States
3.2.2 Market Status by Types in Canada
3.2.3 Market Status by Types in Mexico
3.3 Market Forecast of Drug-Eluting Balloons in North America by Types
CHAPTER 4 NORTH AMERICA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Drug-Eluting Balloons in North America by Downstream Industry
4.2 Demand Volume of Drug-Eluting Balloons by Downstream Industry in Major Countries
4.2.1 Demand Volume of Drug-Eluting Balloons by Downstream Industry in United States
4.2.2 Demand Volume of Drug-Eluting Balloons by Downstream Industry in Canada
4.2.3 Demand Volume of Drug-Eluting Balloons by Downstream Industry in Mexico
4.3 Market Forecast of Drug-Eluting Balloons in North America by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF DRUG-ELUTING BALLOONS
5.1 North America Economy Situation and Trend Overview
5.2 Drug-Eluting Balloons Downstream Industry Situation and Trend Overview
CHAPTER 6 DRUG-ELUTING BALLOONS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN NORTH AMERICA
6.1 Sales Volume of Drug-Eluting Balloons in North America by Major Players
6.2 Revenue of Drug-Eluting Balloons in North America by Major Players
6.3 Basic Information of Drug-Eluting Balloons by Major Players
6.3.1 Headquarters Location and Established Time of Drug-Eluting Balloons Major Players
6.3.2 Employees and Revenue Level of Drug-Eluting Balloons Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 DRUG-ELUTING BALLOONS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Boston Scientific
7.1.1 Company profile
7.1.2 Representative Drug-Eluting Balloons Product
7.1.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of Boston Scientific
7.2 Medtronic
7.2.1 Company profile
7.2.2 Representative Drug-Eluting Balloons Product
7.2.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of Medtronic
7.3 Cook Medical
7.3.1 Company profile
7.3.2 Representative Drug-Eluting Balloons Product
7.3.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of Cook Medical
7.4 C.R. Bard
7.4.1 Company profile
7.4.2 Representative Drug-Eluting Balloons Product
7.4.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of C.R. Bard
7.5 B. Braun
7.5.1 Company profile
7.5.2 Representative Drug-Eluting Balloons Product
7.5.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of B. Braun
7.6 Eurocor GmbH
7.6.1 Company profile
7.6.2 Representative Drug-Eluting Balloons Product
7.6.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of Eurocor GmbH
7.7 Blue Medical
7.7.1 Company profile
7.7.2 Representative Drug-Eluting Balloons Product
7.7.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of Blue Medical
7.8 Bayer
7.8.1 Company profile
7.8.2 Representative Drug-Eluting Balloons Product
7.8.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of Bayer
7.9 Aachen Resonance
7.9.1 Company profile
7.9.2 Representative Drug-Eluting Balloons Product
7.9.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of Aachen Resonance
7.10 Acrostak
7.10.1 Company profile
7.10.2 Representative Drug-Eluting Balloons Product
7.10.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of Acrostak
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF DRUG-ELUTING BALLOONS
8.1 Industry Chain of Drug-Eluting Balloons
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF DRUG-ELUTING BALLOONS
9.1 Cost Structure Analysis of Drug-Eluting Balloons
9.2 Raw Materials Cost Analysis of Drug-Eluting Balloons
9.3 Labor Cost Analysis of Drug-Eluting Balloons
9.4 Manufacturing Expenses Analysis of Drug-Eluting Balloons
CHAPTER 10 MARKETING STATUS ANALYSIS OF DRUG-ELUTING BALLOONS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
